Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Chronic intestinal failure (CIF) is a chronic type of intestinal failure characterized by a nonfunctioning small bowel (that may be reversible or irreversal) where the body is unable to maintain energy and nutritional needs through absorption of food or nutrients via the intestinal tract (despite being metabolically stable) and which therefore necessitates long-term parenteral feeding. CIF may be the result of congenital digestive diseases (such as gastroschisis, atresia of small intestine), short bowel syndrome, intra-abdominal or pelvic cancer, or progressive and devastating gastrointestinal or systemic benign diseases (such as Crohn disease).
Biomarker and diagnostic research for chronic intestinal failure has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 2 NA. Research is primarily sponsored by academic and government institutions.
126 publications have been identified in PubMed for chronic intestinal failure. Research spans Epidemiology / Natural History (36%), Review / Meta-Analysis (32%), and Clinical Trial Publication (11%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 39 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:58 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about chronic intestinal failure
Research summaries | 35 | 32% |
Clinical study results | 12 | 11% |
Patient case studies | 8 | 7% |
Other research | 5 | 5% |
Testing and diagnosis research | 5 | 5% |
Laboratory research | 5 | 5% |
Matysiak K (2026). [PMID: 41683273](https://pubmed.ncbi.nlm.nih.gov/41683273/). *Nutrients*. [Case Report / Case Series]
Saker Y (2026). [PMID: 41107666](https://pubmed.ncbi.nlm.nih.gov/41107666/). *Dig Dis Sci*. [Review / Meta-Analysis]
Schubert L (2026). [PMID: 42105609](https://pubmed.ncbi.nlm.nih.gov/42105609/). *Clin Nutr*. [Epidemiology / Natural History]
González-Salazar LE (2026). [PMID: 41494003](https://pubmed.ncbi.nlm.nih.gov/41494003/). *PLoS One*. [Epidemiology / Natural History]
La L (2026). [PMID: 42128094](https://pubmed.ncbi.nlm.nih.gov/42128094/). *Clin Nutr ESPEN*. [Review / Meta-Analysis]
Ossola M (2026). [PMID: 42155727](https://pubmed.ncbi.nlm.nih.gov/42155727/). *Clin Nutr ESPEN*. [Diagnostic / Biomarker]
Bargas A (2026). [PMID: 42058887](https://pubmed.ncbi.nlm.nih.gov/42058887/). *GE Port J Gastroenterol*. [Review / Meta-Analysis]
Posovszky C (2026). [PMID: 41672430](https://pubmed.ncbi.nlm.nih.gov/41672430/). *Z Gastroenterol*. [Review / Meta-Analysis]
Xia Y (2026). [PMID: 41710275](https://pubmed.ncbi.nlm.nih.gov/41710275/). *Front Nutr*. [Other]
Tabone T (2026). [PMID: 41771423](https://pubmed.ncbi.nlm.nih.gov/41771423/). *Clin Nutr ESPEN*. [Review / Meta-Analysis]
AI-curated news mentioning chronic intestinal failure
Updated Sep 8, 2026
A Korean multicenter retrospective study investigates intestinal failure in children receiving home parenteral nutrition. The findings contribute to understanding the complications and management strategies for this vulnerable population.
Recent research highlights the advancements and ongoing challenges in intestinal transplantation in Australia. The study discusses future directions for improving patient outcomes and addressing the complexities of this rare procedure.
A position paper from the Society for Paediatric Gastroenterology and Nutrition discusses the use of teduglutide in treating short bowel syndrome in infants, children, and adolescents. This guidance aims to inform clinical practices regarding chronic intestinal failure management.